Literature DB >> 12860883

Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.

Vias Markides1, Richard J Schilling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12860883      PMCID： PMC1767799          DOI： 10.1136/heart.89.8.939

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  18 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G de Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

3.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.

Authors:  M A Allessie; F I Bonke; F J Schopman
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

4.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Authors:  D Roy; M Talajic; P Dorian; S Connolly; M J Eisenberg; M Green; T Kus; J Lambert; M Dubuc; P Gagné; S Nattel; B Thibault
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

5.  Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.

Authors:  O D Pedersen; H Bagger; N Keller; B Marchant; L Køber; C Torp-Pedersen
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  Are electrophysiological changes induced by longer lasting atrial fibrillation reversible? :observations using the atrial defibrillator.

Authors:  L M Rodriguez; C Timmermans; H J Wellens
Journal:  Circulation       Date:  1999-07-13       Impact factor: 29.690

7.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

8.  Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

Authors:  J M Rawles; M J Metcalfe; K Jennings
Journal:  Br Heart J       Date:  1990-04

9.  Autonomic tone variations before the onset of paroxysmal atrial fibrillation.

Authors:  Marco Bettoni; Marc Zimmermann
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728
View more
  24 in total

1.  Atrial fibrillation as an uncommon presentation in a large pleomorphic xanthoastrocytoma.

Authors:  Sadettin Sezer; Ali Baykan; Ebru Yilmaz; Ekrem Unal; Sertaç Hanedan Onan; Ali Yikilmaz; Kazım Uzum; Mehmet Akif Ozdemir; Nazmi Narin
Journal:  Childs Nerv Syst       Date:  2011-11-16       Impact factor: 1.475

Review 2.  Diet and risk of atrial fibrillation – epidemiologic and clinical evidence –.

Authors:  Noelle N Gronroos; Alvaro Alonso
Journal:  Circ J       Date:  2010-09-11       Impact factor: 2.993

3.  Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study).

Authors:  David D McManus; Kahraman Tanriverdi; Honghuang Lin; Nada Esa; Menhel Kinno; Divakar Mandapati; Stanley Tam; Okike N Okike; Patrick T Ellinor; John F Keaney; J Kevin Donahue; Emelia J Benjamin; Jane E Freedman
Journal:  Heart Rhythm       Date:  2014-10-09       Impact factor: 6.343

Review 4.  Atrial fibrillation: review of current treatment strategies.

Authors:  Joshua Xu; Jessica G Y Luc; Kevin Phan
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.

Authors:  Peter Y Cai; Roselle Derequito; Monica Mishra; Spandana Tenkabail; Aakash Bodhit; Saeed Ansari; Sarah Ganji; Pradeepan Saravanapavan; Chandana Chandra Shekhar; Fawzi Abukhalil; Michael F Waters; Thomas M Beaver; Vishnumurthy Shushrutha Hedna
Journal:  J Surg (Northborough)       Date:  2013-10-14

6.  Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials.

Authors:  Peter Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

Review 7.  Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

Authors:  Harry J G M Crijns
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.

Authors:  M Barman
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 9.  Risk Factors for the Development of Atrial Fibrillation in HIV Infected Patients.

Authors:  Yaser Elnahar; Joseph Daoko; Anthony Al-Dehneh; Nishant Gupta; Vincent A DeBari; Fayez Shamoon; Constantinos A Costeas
Journal:  J Atr Fibrillation       Date:  2012-04-14

10.  Prognostic Value of Atrial Fibrillation Inducibility in Patients Without History of Clinical Atrial Fibrillation.

Authors:  Jonathan Marquardt; Kira Marquardt; Christian Scheckenbach; Wenzhong Zhang; Fabian Stimpfle; Martin Duckheim; Carole Maleck; Peter Seizer; Meinrad Gawaz; Jürgen Schreieck; Michael Gramlich
Journal:  J Atr Fibrillation       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.